Hem › Prostatacancer › Massachusetts › Boston
Kliniska studier för Prostatacancer i Boston, MA
59 studier för Prostatacancer söker deltagare vid platser i och runt Boston (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekryterarFas 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Distance-Based Exercise to Preserve Function and Prevent Disability
Rekryterar
- Dana-Farber Cancer Institute, Boston
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekryterarFas 1
- Massachusetts General Hospital, Boston
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
RekryterarFas 4
- Massachusetts General Hospital, Boston
Precision-Based Genomics in Prostate Cancer
RekryterarObservationsstudie
- Dana Farber Cancer Institute, Boston, MA, Boston
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
Rekryterar
- Dana Farber Cancer Institute, Boston
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
RekryterarFas 1/2
- Research Site, Boston
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
RekryterarFas 1/2
- Dana Farber Mass General Brigham Cancer Care Inc, Boston
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
RekryterarFas 1
- Harvard Medical School-Massachusetts General Hospital, Boston
Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes
Rekryterar
- Dana-Farber Cancer Institute, Boston
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
RekryterarFas 1
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
RekryterarFas 2/3
- Dana Farber Cancer Institute, Boston
- Beth Israel Deaconess Medical Center, Boston
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
RekryterarFas 1
- Mass General Hospital, Boston
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekryterarFas 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
RekryterarFas 3
- Beth Israel Deaconess Med Center, Boston
- Dana Farber Cancer Institute, Boston
CV CARE: CardioVascular Care in PC Patients
Rekryterar
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RekryterarFas 3
- Beth Israel Deaconess Medical Center ( Site 0043), Boston
- Dana Farber Cancer Institute ( Site 0012), Boston
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
RekryterarFas 1
- Dana-Farber Cancer Institute, Boston
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RekryterarFas 3
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
Rekryterar
- Beth Israel Deaconess Medical Center, Boston
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Serial MRI Scans During Radiation Therapy
Rekryterar
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Prostate Active Surveillance Study
RekryterarObservationsstudie
- Beth Israel Deaconess Medical Center/Harvard Medical School, Boston
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
RekryterarFas 2
- Dana Farber Cancer Institute, Boston
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
RekryterarFas 2
- Brigham and Women's Hospital, Boston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
RekryterarFas 2
- Dana-Farber Cancer Institute / Beth Israel Deaconess Medical Center, Boston
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
RekryterarFas 1/2
- Research Site, Boston
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
RekryterarFas 1
- Dana-Farber Cancer Institute, Boston
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
RekryterarFas 2
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
Rekryterar
- Dana Farber Cancer Institute, Boston
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
RekryterarFas 3
- Dana-Farber Cancer Institute, Boston
Jump: MR Simulation For Radiation Therapy Master Protocol
Rekryterar
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
RekryterarFas 1
- Dana Farber Cancer Institute, Boston
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
RekryterarFas 1
- Dana Farber Cancer Institute, Boston
Androgen-responsive POSLUMA-guided Intra-prostatic Boost
RekryterarFas 2
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Video Education With Result Dependent dIsclosure
Rekryterar
- Dana Farber Cancer Institute, Boston
Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)
RekryterarFas 3
- Brigham and Women's Hospital, Boston
- Brigham and Women's Faulkner Hospital, Boston
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
RekryterarObservationsstudie
- Dana-Farber Cancer Institute, Boston
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
RekryterarObservationsstudieFriska volontärer välkomna
- Massachusetts General Hospital, Boston
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
RekryterarObservationsstudie
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
RekryterarFas 1
- Research Site, Boston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RekryterarFas 1/2
- Massachusetts General Hospital, Boston
Clinical Trial of Approaches to Prostate Cancer Surgery
Rekryterar
- Beth Israel Deaconess Medical Center (BIDMC), Boston
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
RekryterarFas 1/2
- Dana-Farber Cancer Institute, Boston
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
RekryterarFas 2/3
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
RekryterarFas 1
- Dana Farber Cancer Institute, Boston
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekryterarFas 1/2
- Massachusetts General Hospital, Boston
Study of AZD0754 in Participants With Metastatic Prostate Cancer
RekryterarFas 1/2
- Research Site, Boston
- Research Site, Boston
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
RekryterarFas 4
- Dana Farber Cancer Institute, Boston
- Brigham and Womens Hospital, Boston
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
RekryterarFas 4
- Massachussets General Hospital, Boston
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)
RekryterarFriska volontärer välkomna
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
MRI Guided Prostate Biopsy
Rekryterar
- Brigham and Women's Hospital, Boston
Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy
RekryterarObservationsstudie
- Massachsuetts General Hospital, Boston
Stereotactic Magnetic Resonance Guided Radiation Therapy
Rekryterar
- Brigham & Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
RekryterarFriska volontärer välkomna
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
RekryterarFas 1
- Dana Farber Cancer Institute, Boston
- Brigham and Womens Hospital, Boston
Comprehensive Outcomes for After Cancer Health
RekryterarFriska volontärer välkomna
- Dana Farber Cancer Institute, Boston
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
RekryterarObservationsstudie
- Massachusetts General Hospital, Boston
Prostate Cancer Genetic Risk Evaluation and Screening Study
RekryterarObservationsstudie
- Massachusetts General Hospital, Boston
Prostatacancer-studier i andra städer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN42 studier
- Seattle, WA42 studier
- Washington, DC38 studier
- Dallas, TX36 studier
Andra studier i Boston
- Bröstcancer111 studier
- Icke-småcellig lungcancer90 studier
- Cancer (alla typer)86 studier
- Kolorektal cancer63 studier
- Metastaserande cancer63 studier
- Lungcancer62 studier
- Äggstockscancer61 studier
- Depression52 studier
- Endometriecancer50 studier
- Hjärtsvikt44 studier
- Akut myeloid leukemi44 studier
- Bukspottkörtelcancer43 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.